<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E4F6BEA-8E66-490E-B61F-8CBB33116179"><gtr:id>5E4F6BEA-8E66-490E-B61F-8CBB33116179</gtr:id><gtr:name>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60DD1416-9DC9-4844-8A53-3B17E8F3F970"><gtr:id>60DD1416-9DC9-4844-8A53-3B17E8F3F970</gtr:id><gtr:name>Witten-Herdecke University</gtr:name><gtr:address><gtr:line1>Witten-Herdecke University</gtr:line1><gtr:line2>Stockumer Strasse 10</gtr:line2><gtr:postCode>D58448</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Health Science</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E4F6BEA-8E66-490E-B61F-8CBB33116179"><gtr:id>5E4F6BEA-8E66-490E-B61F-8CBB33116179</gtr:id><gtr:name>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60DD1416-9DC9-4844-8A53-3B17E8F3F970"><gtr:id>60DD1416-9DC9-4844-8A53-3B17E8F3F970</gtr:id><gtr:name>Witten-Herdecke University</gtr:name><gtr:address><gtr:line1>Witten-Herdecke University</gtr:line1><gtr:line2>Stockumer Strasse 10</gtr:line2><gtr:postCode>D58448</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3EFDAE42-14E8-44C9-826E-98AE6C070F04"><gtr:id>3EFDAE42-14E8-44C9-826E-98AE6C070F04</gtr:id><gtr:firstName>Cynthia</gtr:firstName><gtr:otherNames>Paola</gtr:otherNames><gtr:surname>Iglesias</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501892"><gtr:id>B17A7D84-D3C6-4DE2-86E3-8A3498B9227D</gtr:id><gtr:title>Evidence Synthesis as a tool for the Evaluation of Therapeutic Medical Devices</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501892</gtr:grantReference><gtr:abstractText>Publicly funded healthcare systems are under increasing financial and political pressure to allocate their limited healthcare resources in a way that the health benefit for the society is maximised. To this end several countries / jurisdictions have set up formal healthcare evaluation processes aiming to establish if healthcare treatments represent good value for money. In the UK, the National Institute for Health and Clinical Excellence (NICE) has responsibility for recommending the adoption of healthcare treatments, based on evidence regarding their clinical and cost effectiveness.
The introduction of medical devices into the European Union does not require the same level of scrutiny as that for pharmaceuticals. Recently innovative methods of bringing together clinical evidence on effectiveness of treatments and economic data on the resources used have been developed and are beginning to be used by NICE. In this project I will systematically examine the potential use of these methods to appraise medical devices. The results of this reseach project will inform the decisions of national healthcare regulatory agencies.</gtr:abstractText><gtr:technicalSummary>The research objectives are to: (i) investigate the methods for generating cost effectiveness evidence for therapeutic medical devices. (ii) test out evidence synthesis methods to investigate the relative cost-effectiveness of medical devices using chronic venous leg ulceration as a tracer condition. (iii) explore alternative methods of evidence synthesis to integrate summary data with patient level economic and clinical data. The research methods include systematic review of the literature, comparative analysis, qualitative research with healthcare policy makers involving semi-structured interviews, and Bayesian evidence synthesis methods (among them mixed treatment comparisons; generalised evidence synthesis; multi-parameter evidence synthesis; comprehensive decision analytic modelling) using summary and patient level data. The delivery of this project will provide a formal framework for the evaluation of medical devices for the treatment of specific health conditions which can be used to inform healthcare decision making regarding adoption decisions.</gtr:technicalSummary><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>289086</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>YHEC and the NTH NHS Foundation External Assessment Centre</gtr:description><gtr:id>30447456-735F-4876-9DFD-44B351B15718</gtr:id><gtr:impact>Reviewed and commented on a report on medical device evaluation that was submitted to NICE.
Craig JA, Carr L, Hutton J, Glanville J, Iglesias CP, Sims AJ. A Review of the Economic Tools for Assessing New Medical Devices. Appl Health Econ Health Policy. 2014 Aug 20.</gtr:impact><gtr:outcomeId>eqxpwhEBvm1-1</gtr:outcomeId><gtr:partnerContribution>They produce assessment reports to support the activity ofNICE's Evaluation Pathway Programme for Medical Devices</gtr:partnerContribution><gtr:piContribution>I am member of the advisory group for the York Health Economics Consortium and the Newcastle upon Tyne Hospitals NHS Foundation Trust External Assessment Centre for the Evaluation Pathway Programme for Medical Devices</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>York Health Economics Consortium (YHEC)</gtr:department><gtr:description>YHEC and the NTH NHS Foundation External Assessment Centre</gtr:description><gtr:id>2F92BC82-5629-49FE-BD34-0FC3B6DEAE20</gtr:id><gtr:impact>Reviewed and commented on a report on medical device evaluation that was submitted to NICE.
Craig JA, Carr L, Hutton J, Glanville J, Iglesias CP, Sims AJ. A Review of the Economic Tools for Assessing New Medical Devices. Appl Health Econ Health Policy. 2014 Aug 20.</gtr:impact><gtr:outcomeId>eqxpwhEBvm1-2</gtr:outcomeId><gtr:partnerContribution>They produce assessment reports to support the activity ofNICE's Evaluation Pathway Programme for Medical Devices</gtr:partnerContribution><gtr:piContribution>I am member of the advisory group for the York Health Economics Consortium and the Newcastle upon Tyne Hospitals NHS Foundation Trust External Assessment Centre for the Evaluation Pathway Programme for Medical Devices</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Witten/Herdecke University (UWH)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>ZKS - Center for Clinical Studies</gtr:department><gtr:description>European Clinical Research Infrastructures Network (ECRIN)</gtr:description><gtr:id>ADEEEC20-8024-4184-9F7B-D13321E2DBE6</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>FBe4k4XF8jK-1</gtr:outcomeId><gtr:partnerContribution>The Center for Clinical Studies (ZKS) is involved in leading a work package within the European Clinical Research Infrastructures Network (ECRIN). ECRIN is a sustainable, not-for-profit infrastructure supporting multinational clinical research projects in Europe funded by the EU. It is based on the connection of coordinating centres for national networks of clinical research centres and clinical trial units with the aim to provide information as well as consultation to investigators and sponsors in the preparation and conduct of multinational clinical studies focusing on specific areas, such as: rare diseases (work package 4), medical devices (work package 5) and nutrition (work package 6).</gtr:partnerContribution><gtr:piContribution>Member of methodology panel for the work package on medical devices (WP5) of the European Clinical Research Infrastructures Network (ECRIN)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Autonomy - Risk Evidence and Decision Making</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>50FA006F-2D58-4AAF-BDD9-955AA21353EC</gtr:id><gtr:impact>EPSRC Sandpit. York, February 2016. Identify high priority project proposals to allocate pump priming funds.</gtr:impact><gtr:outcomeId>58b5629ee6ee86.42421765</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Stroke Organisation Workshop on Stroke Device Trials</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60F4018D-2E84-4351-B0BD-EB03881CEDE0</gtr:id><gtr:impact>20 representatives of the stroke medical device manufacture industry and specialist clinicians in stroke attended this two day workshop focused on different aspects of the design and analysis of stroke device trials.

A paper describing the content of presentations and debate is now being drafted and will be submitted for publication.</gtr:impact><gtr:outcomeId>DB3Do1c1Bmu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Experience of pharmaceuticals and medical devices HTA</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B331BD0-C80D-471C-9FAE-287A0164B08D</gtr:id><gtr:impact>Invited presentation to Sanofi, Italy. This was a professional training activity coordinated by the LUISS University, Rome Italy</gtr:impact><gtr:outcomeId>56e014239af455.65381648</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Health Economics Association World Congress</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B0B208C5-4069-465B-BA09-5BDCF44C5B46</gtr:id><gtr:impact>Session organiser: Iglesias CP. Speakers: Bojke L, Jackson C, Soares M. Explicit Characterization of Uncertainty in Health Technology Assessment: Structural and Other Uncertainties. Organised session presented at the 7th World Congress of the International Health Economics Association. Beijing, China. July 2009.

This was one of the first forums in which the need and value of explicitly recognizing and characterizing the kind and level of uncertainty associated with economic evaluation analyses was discussed.</gtr:impact><gtr:outcomeId>Euq29BPt48F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Healthcare Decision Making and Makers in UK, Germany and Sweden: A Comparative Perspective.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2710D4D2-92B4-4107-8726-7E4CE1962F0D</gtr:id><gtr:impact>1st Specialised Workshop in Healthcare Policy and Pharmacoeconomics organised by the Pompeu Fabra University. June 2016, Mallorca, Spain. Fellow health economists reported to have improved their understanding of HTA processes in Europe.</gtr:impact><gtr:outcomeId>58b55fa0801817.35133115</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Person-centred healthcare research at York</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8461DAFC-83EE-4846-BF28-142CCEE0E490</gtr:id><gtr:impact>One day interdisciplinary collaborative event at York. June 2016, that resulted in a network of colleagues working in person-centre healthcare research having been established.</gtr:impact><gtr:outcomeId>58b58d88e724a0.67065461</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Introduction to health technology assessment</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0A0F7E7-8B36-4912-8C91-3138495D01E1</gtr:id><gtr:impact>Invited 5 day curse as part of the Summer School organised by the Department of Public Health of the Universidad Nacional Aut&amp;oacute;noma de M&amp;eacute;xico</gtr:impact><gtr:outcomeId>56e014f7e78ee6.71822302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MedtecHTA: Methods for Health Technology Assessment of Medical Devices: A European Perspective Project Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6A5865EA-88EE-4DC4-99A6-F2BE91F0A976</gtr:id><gtr:impact>20 academics from 6 different countries who are collaborating in a European consortium (MedtecHTA) over a two day workshop discussed alternative ways to purse an international collaborative program of work. I presented a view on the methodological issues associated with the evidence base usually available to evaluate medical devices. I also provided expert input regarding the regulation of medical devices at international level.

A number of agreements were made and the fisrt two work packages of a total of 6 were started.</gtr:impact><gtr:outcomeId>DVMG2UvW5BZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.medtechta.eu</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MedtecHTA: Methods for Health Technology Assessment of Medical Devices: A European Perspective. Project Kick off Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D4FBC6B-EAE8-4D14-A797-C4A65057D39E</gtr:id><gtr:impact>20 academics representing 6 universities gathered to officially get started the MedtecHTA project. This is a European funded initiative to improve the existing methodological framework within the paradigm of Health Technology Assessment (HTA) for the assessment of medical devices, and to develop this framework into a tool that provides structured, evidence-based input into health policies

A final programme of work and collaborations were agreed.</gtr:impact><gtr:outcomeId>PD251fenvQG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HEFCE Catalyst &quot;Medical Technologies Innovation Workshop&quot;</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>33C25826-CE3E-4D48-A90B-0EB5E93F1219</gtr:id><gtr:impact>Initiative to facilitate interactions between academics and industry in the field of medical technology. Collaborative initiative Leeds, York, Bradford, Huddersfield, and Leeds Beckett. March 2016</gtr:impact><gtr:outcomeId>58b563adc3a4c6.20024452</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop &quot;Challenges in demonstrating the socio-economic benefits of medical devices' organised at EHTI LSE</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>68956FB7-3A1B-4696-BB9E-C637BA127D94</gtr:id><gtr:impact>How can we design RCTs for medical devices? An exploration of the problems faced and practical tips that can help overcome them. Presented at a workshop on Challenges in demonstrating the socio-economic benefits of medical devices, organised at EHTI LSE. Sep 2012.

Feedback from workshop participants indicated that the session had raised their awareness not only on the need and value of generating a high quality evidence base on the clinical and value for money of medical devices but also of research methods that could be used to design and implement primary reseach</gtr:impact><gtr:outcomeId>Kn51iHBLgzM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISPOR Conference Issue Panel 4. Does Assessing the Value for Money of Medical Devices Require a Flexible Approach?</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9899D8FF-104B-48B7-83AD-51772ECD500E</gtr:id><gtr:impact>The International Society for Pharmacoeconomics and Outcomes Research has representatives from the drug and medical device industries as well as from academic, regulation and health technology assessment sectors. Issue panel are peer reviewed according to criteria of timeliness, relevance and academic excellence.


The attendance to this year Euopean ISPOR meeting was over 4000 people. The feedback from the issue panel I organised and moderated was very positive and resulted in agreements for future collaborations and research activities.</gtr:impact><gtr:outcomeId>F69pjrTzQe3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How to introduce health technology assessment to in clinical studies in Myeloma</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DF08643E-9030-4421-BA52-12BFD05D3D48</gtr:id><gtr:impact>This was an invited plenary session at the 15th International Myeloma Workshop</gtr:impact><gtr:outcomeId>56e013363474d4.03994354</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISPOR Latinamerica Biannual Meeting: Workshop on Challenges of Medical Devices for Economic Assessments:a Perspective from Latinamerica</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>76AB9779-7F42-468D-AE93-1447ACFDC0B2</gtr:id><gtr:impact>I was invited to deliver a presentation on methodological differences in the evaluation of medical devices and drugs

The session was well attended and motivated an interesting debate.</gtr:impact><gtr:outcomeId>Bp1529sNisc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>222838</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Methods for Health Technology of Medical Devices: A European Perspective</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>17447A02-536F-403E-87C6-678D72CFCE12</gtr:id><gtr:outcomeId>5461eb18116954.60413306</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>159000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Technology Assessment</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>13/30/02</gtr:fundingRef><gtr:id>29882C4C-60CD-4DFF-A7DE-1D659882364A</gtr:id><gtr:outcomeId>ScWrrFi1wxK</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>Luxembourg, Grand Duchy of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Luxemburg Institute of Health</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Luxemburg Institute of Health</gtr:fundingOrg><gtr:id>DCC78C75-C074-47DD-9BBA-06C26B5AFECC</gtr:id><gtr:outcomeId>56e01d3b22a937.97429945</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7376EC13-8053-4862-8534-5187D20CFD10</gtr:id><gtr:outcomeId>56e01be942f932.25262920</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1041717</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA programme</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>3A511208-2BFF-47C3-A357-EABDA55E0421</gtr:id><gtr:outcomeId>ivXAnPM85pX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR research programme</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>EA9B4A10-16E1-4790-835F-843689CCCF6D</gtr:id><gtr:outcomeId>hCfrXxfeHyC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155800</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A study into the operation of discrete choices to understand how people value self-management support interventions</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>The Health Foundation</gtr:fundingOrg><gtr:id>9399E745-77B4-4505-BB73-26F3C23C4868</gtr:id><gtr:outcomeId>5461e6084495f8.14400873</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102429</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The economics of stratified medicine in rheumatoid arthritis</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>356D3C74-33D7-4FC5-9D17-27F7B039C305</gtr:id><gtr:outcomeId>5461e6d60b4c45.53891964</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214949</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC methods project</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B40E6734-EB45-4F48-8E57-CB21E4E14B3E</gtr:id><gtr:outcomeId>JmpCxtNQhGA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Medical Technologies Advisory Committee of the National Institute for Health and Clinical Excellence</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C0C93D68-F29C-42F6-89F9-F3D23E232043</gtr:id><gtr:outcomeId>J1xkypyj5nT</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8CB5EDFD-D424-4231-95BC-BA35F814DACD</gtr:id><gtr:title>Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e165b111e2507b8f00708c83f8e5a1f6"><gtr:id>e165b111e2507b8f00708c83f8e5a1f6</gtr:id><gtr:otherNames>Ashby RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5460a39dee3151.35412629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A0825EE-0F70-4124-B656-7594D2D87318</gtr:id><gtr:title>Economics of stratified medicine in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Current rheumatology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/555e7540bab196ec0dc80e38eb968921"><gtr:id>555e7540bab196ec0dc80e38eb968921</gtr:id><gtr:otherNames>Gavan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-3774</gtr:issn><gtr:outcomeId>5460a20cc80418.61702434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCE0FE05-69E0-47A4-BA47-A9AC0CA72E2A</gtr:id><gtr:title>Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: systematic review, qualitative study, survey and costing analysis.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ce060460afd7ecfb47de3afe705795"><gtr:id>95ce060460afd7ecfb47de3afe705795</gtr:id><gtr:otherNames>O'Connor J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>58b5499ee494b3.27262809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C7075F3-4094-44EF-BE6A-E1345D992BFC</gtr:id><gtr:title>A review of the economic tools for assessing new medical devices.</gtr:title><gtr:parentPublicationTitle>Applied health economics and health policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f060012bf47b3fa5f2c66b7bd243a0"><gtr:id>25f060012bf47b3fa5f2c66b7bd243a0</gtr:id><gtr:otherNames>Craig JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1175-5652</gtr:issn><gtr:outcomeId>5460a39e4607d3.03877695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B8D61B2-73C7-4FBB-B2FB-D83564C19E48</gtr:id><gtr:title>Methods to assess cost-effectiveness and value of further research when data are sparse: negative-pressure wound therapy for severe pressure ulcers.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/410b2df32adbc9d15ed167f05d421fba"><gtr:id>410b2df32adbc9d15ed167f05d421fba</gtr:id><gtr:otherNames>Soares MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_14891_21_22927694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>326BC302-1FC7-4E75-861D-F7DEB6038EC2</gtr:id><gtr:title>VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e165b111e2507b8f00708c83f8e5a1f6"><gtr:id>e165b111e2507b8f00708c83f8e5a1f6</gtr:id><gtr:otherNames>Ashby RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>5460a39e6dd657.14185551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F1551AE-2A85-453C-B562-64EFBC4F5FBB</gtr:id><gtr:title>A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9462ec9f39a4084c3fda0414f0692484"><gtr:id>9462ec9f39a4084c3fda0414f0692484</gtr:id><gtr:otherNames>Schnell-Inderst P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>58b5499f38b064.27944867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BFBD816-F81E-43C0-B95D-AA00E6330BB5</gtr:id><gtr:title>Commentary: Europe needs a central, transparent, and evidence based regulation process for devices.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56298c0ab300a432b524f839ef70ffcd"><gtr:id>56298c0ab300a432b524f839ef70ffcd</gtr:id><gtr:otherNames>Eikermann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_14891_21_23653340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F87BDF2-55E4-48C6-AF6C-ACC632244106</gtr:id><gtr:title>Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different?</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d91f9ac3cfe9870946ff4a51ab0e8437"><gtr:id>d91f9ac3cfe9870946ff4a51ab0e8437</gtr:id><gtr:otherNames>Taylor RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>XoHqhJPEpbt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9EAA7D4-5014-4151-B0DE-B877F054B8C7</gtr:id><gtr:title>Systematic review of the evidence on orthotic devices for the management of knee instability related to neuromuscular and central nervous system disorders.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20ddb6ebba77c43cb6ef232a24edfbaf"><gtr:id>20ddb6ebba77c43cb6ef232a24edfbaf</gtr:id><gtr:otherNames>McDaid C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a9560f5de6322.69689156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0D87A5B-E41F-4CE2-BDD5-E3CE6FDA5CD6</gtr:id><gtr:title>Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a68df65d801d50852fef761a5fef43cf"><gtr:id>a68df65d801d50852fef761a5fef43cf</gtr:id><gtr:otherNames>Iglesias CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>58b5499f151380.85989702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2617D40-CF86-471E-9680-9A97CCDE742B</gtr:id><gtr:title>Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/410b2df32adbc9d15ed167f05d421fba"><gtr:id>410b2df32adbc9d15ed167f05d421fba</gtr:id><gtr:otherNames>Soares MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>ANzWXcjkzpc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A0A3205-0AF7-4815-BAC1-749EFDCCDA49</gtr:id><gtr:title>Testing devices for the prevention and treatment of stroke and its complications.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5460a39e211fd5.04083174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99DF93BD-45FD-42E6-898C-17B67A6D7BF3</gtr:id><gtr:title>Does assessing the value for money of therapeutic medical devices require a flexible approach?</gtr:title><gtr:parentPublicationTitle>Expert review of pharmacoeconomics &amp; outcomes research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a68df65d801d50852fef761a5fef43cf"><gtr:id>a68df65d801d50852fef761a5fef43cf</gtr:id><gtr:otherNames>Iglesias CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-7167</gtr:issn><gtr:outcomeId>56e00ff0ba8940.85220144</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501892</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4CFCFE99-281F-452D-9C77-757ECDBEB0DC</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.3  Medical devices</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>